The total return over the past 12 months is -39.59% vs. +16.94% for the S&P 500. So far it's up -68.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (39.59%) | (1.52%) | (47.22%) | N/A | N/A | N/A |
| Total Return CAGR | (39.59%) | (1.52%) | (47.22%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Connect Biopharma Holdings Limited (CNTB)
| Year | Start price | End price | CNTB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.82 | $0.90 | (68.16%) | +14.51% | (82.67%) |
| 2025 | $1.38 | $2.82 | +104.35% | +17.72% | +86.63% |
| 2024 | $1.18 | $1.38 | +16.95% | +24.89% | (7.94%) |
| 2023 | $0.87 | $1.18 | +35.94% | +26.19% | +9.75% |
| 2022 | $5.15 | $0.87 | (83.15%) | (18.17%) | (64.98%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
